92 results
8-K
EX-4.1
NBSE
NeuBase Therapeutics Inc
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental … (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock
8-K
NBSE
NeuBase Therapeutics Inc
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
Transactions, the holder of the New Warrant will be entitled to receive consideration in an amount equal to the Black Scholes value of the New Warrant
8-K
EX-4.2
d3hg 6dok
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-4.1
06rux0i
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
c3c953dg
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-4.5
g6iqh9dxhz7tc 5l
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
424B5
eu54pi m0nl
30 Jun 23
Prospectus supplement for primary offering
8:42am
424B5
hdz4h 8vcgi
29 Dec 22
Prospectus supplement for primary offering
5:03pm
424B5
l4u765u xe29hr
27 Aug 21
Prospectus supplement for primary offering
5:21pm